tiprankstipranks
Zevra Therapeutics (ZVRA)
NASDAQ:ZVRA

Zevra Therapeutics (ZVRA) Cash flow

711 Followers

Zevra Therapeutics Cash Flow

ZVRA's free cash flow for Q3 2023 was $―. For the 2023 fiscal year, ZVRA's free cash flow was decreased by $-29.15M and operating cash flow was $-4.63M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -21.84M$ -18.72M$ 10.44M$ -1.94M$ -23.74M$ -54.20M
Investing Cash Flow
$ -28.04M$ -36.72M$ -15.52M$ -33.00K$ 3.23M$ 33.33M
Financing Cash Flow
$ 23.20M$ 8.35M$ 113.11M$ 2.74M$ 4.94M$ 28.02M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 213.33M$ 65.47M$ 112.35M$ 4.32M$ 3.56M$ 19.12M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
$ 612.00K$ 321.00K$ 218.00K$ 78.00K$ 5.36M$ 5.54M
Issuance Of Capital Stock
---$ 0.00$ 5.45M$ 28.33M
Issuance Of Debt
$ 25.99M$ 12.78M$ -38.10M$ 3.08M$ 5.45M-
Repayment Of Debt
$ -13.01M$ -16.00K$ -38.10M$ -227.00K$ -207.00K$ -193.00K
Free Cash Flow
$ -17.30M$ -18.81M$ 10.34M$ -1.97M$ -23.76M$ -54.22M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Zevra Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis